Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adamis Pharmaceuticals Corp    ADMP

ADAMIS PHARMACEUTICALS CORP (ADMP)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

ADAMIS PHARMACEUTICALS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/10/2018 | 10:19pm CEST

Item 2.02 Results of Operations and Financial Conditions

On August 10, 2018, Adamis Pharmaceuticals Corporation (the "Company") issued a press release announcing certain financial information for the quarter ended June 30, 2018. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Form 8-K and the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits.


Exhibit No. Exhibit Description

99.1 Press release dated August 10, 2018

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ADAMIS PHARMACEUTICALS COR
08/10ADAMIS PHARMACEUTICALS CORP : Results of Operations and Financial Condition, Fin..
AQ
08/10ADAMIS : 2Q Earnings Snapshot
AQ
08/10Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Bu..
GL
08/09ADAMIS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
AQ
08/06ADAMIS PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock an..
AQ
08/03ADAMIS PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
AQ
08/02ADAMIS PHARMACEUTICALS CORP : Entry into a Material Definitive Agreement, Other ..
AQ
08/02Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
GL
08/01Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
GL
07/23Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate..
GL
More news
News from SeekingAlpha
08/10Adamis Pharma Q2 revenues up 3%; shares down 2% 
08/10Adamis Pharmaceuticals misses on revenue 
08/02Adamis Pharmaceuticals prices equity offering, shares down 4.5% premarket 
07/09Adamis Pharma files for $150M mixed shelf offering; shares down 4% after hour.. 
07/09Adamis Pharma files for $150M mixed shelf offering; shares down 4% after hour.. 
Financials ($)
Sales 2018 21,5 M
EBIT 2018 -25,1 M
Net income 2018 -27,3 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 7,59x
Capi. / Sales 2019 4,58x
Capitalization 163 M
Chart ADAMIS PHARMACEUTICALS CORP
Duration : Period :
Adamis Pharmaceuticals Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAMIS PHARMACEUTICALS COR
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 9,75 $
Spread / Average Target 191%
EPS Revisions
Managers
NameTitle
Dennis J. Carlo President, Chief Executive Officer & Director
Richard C. Williams Chairman
Karen K. Daniels Vice President-Operations
Robert O. Hopkins Chief Financial Officer, Secretary & VP-Finance
Thomas H. Moll Vice President-Research
Sector and Competitors
1st jan.Capitalization (M$)
ADAMIS PHARMACEUTICALS CORP-23.86%163
JOHNSON & JOHNSON-7.31%349 348
PFIZER12.40%238 721
NOVARTIS-1.07%209 761
ROCHE HOLDING LTD.-2.84%207 063
MERCK AND COMPANY18.11%177 444